THE KIDNEY CANCER ASSOCIATION

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1990

Legal Domicile

Principal Officer

GRETCHEN E VAUGHAN

Phone

8008509132

Tax Period

2023-11-01 to 2024-10-31

THE KIDNEY CANCER ASSOCIATION, founded in 1990, is a community nonprofit in the Medical Research sector that reported $4.9M in total revenue in fiscal year 2023. Revenue surged 108% from the prior year, signaling strong growth momentum. Net assets of $24.8M represent 60 months of operating reserves.

Mission

THE KIDNEY CANCER ASSOCIATION IS A GLOBAL COMMUNITY DEDICATED TO SERVING AND EMPOWERING PATIENTS, AND LEADING CHANGE THROUGH ADVOCACY, RESEARCH, AND EDUCATION IN ORDER TO BE THE UNIVERSAL LEADER IN FINDING THE CURE FOR KIDNEY CANCER.

Program Service Accomplishments

Program 1

Expenses: $1,657,564

EDUCATION - THE KIDNEY CANCER ASSOCIATION PROVIDES OPPORTUNITIES FOR PHYSICIANS, RESEARCHERS, ACADEMICS, AND INDUSTRY PROFESSIONALS FROM ACROSS THE GLOBE TO COME TOGETHER AND EXCHANGE IDEAS THAT WILL DIRECT THE FUTURE OF KIDNEY CANCER RESEARCH AND TREATMENT IN THE ULTIMATE PURSUIT OF A CURE. THE PRIMARY OPPORTUNITIES ARE DURING THE TWO ANNUAL SYMPOSIA, IKCS NORTH AMERICA AND IKCS EUROPE, HELD BOTH IN PERSON. IKCS MEETINGS PROMOTE LEARNING, NETWORKING, AND UNPARALLELED OPPORTUNITIES FOR MENTORSHIP AND COLLABORATION.

Program 2

Expenses: $1,391,350 Revenue: $262,709

PATIENT SUPPORT AND ADVOCACY - THE KIDNEY CANCER ASSOCIATION SEEKS TO BE A SOURCE OF EDUCATION AND RESOURCES FOR PATIENTS, CAREGIVERS, AND ANYONE IMPACTED BY KIDNEY CANCER. THE KCA PROVIDES PATIENT RESOURCES FOR EACH STAGE OF THE KIDNEY CANCER JOURNEY INCLUDING OUR JUST DIAGNOSED TOOLKIT, PATIENT NAVIGATOR PROGRAM, VIRTUAL PATIENT SYMPOSIUM, KCA CONNECT, PATIENT ASSISTANCE FUND, AND EDUCATIONAL RESOURCES INCLUDING INFORMATION ON TREATMENTS, DRUGS, CLINICAL TRIALS, AND CAREGIVING TO NAME A FEW.

Program 3

Expenses: $815,824

RESEARCH - THE KIDNEY CANCER ASSOCIATION IS COMMITTED TO SUPPORTING HEALTHCARE PROFESSIONALS, FOSTERING PROFESSIONAL COLLABORATION, AND FUNDING RESEARCH THAT ADVANCES OUR UNDERSTANDING OF KIDNEY...

RESEARCH - THE KIDNEY CANCER ASSOCIATION IS COMMITTED TO SUPPORTING HEALTHCARE PROFESSIONALS, FOSTERING PROFESSIONAL COLLABORATION, AND FUNDING RESEARCH THAT ADVANCES OUR UNDERSTANDING OF KIDNEY CANCER. THE ORGANIZATION AWARDED GRANTS TO PHYSICIANS AND SCIENTISTS ENGAGED IN RESEARCH TARGETING EARLY DETECTION AND INNOVATIVE TREATMENTS FOR KIDNEY CANCER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $3,468,895

Program Service Revenue $249,037

Investment Income $1,191,650

Other Revenue $32,447

TOTAL REVENUE $4,942,029

Expense Breakdown

Grants Paid $387,698

Salaries & Benefits $2,669,682

Fundraising Expenses $363,660

Program Expenses $3,864,738

Other Expenses $2,216,230

TOTAL EXPENSES $5,273,610

Year-over-Year Comparison

	2023	2022	Change
Revenue	$4,942,029	$2,379,639	+1.1%
Expenses	$5,273,610	$4,741,209	+0.1%
Net Income	$-331,581	$-2,361,570	-0.9%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

226

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,086,558

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BRADLEY LEIBOVICH MD	BOARD CHAIR	1.00	Officer Director	$0	$0	$0
RYAN NATZKE	VICE CHAIR	0.50	Officer Director	$0	$0	$0
JOEL STERN	TREASURER	0.50	Officer Director	$0	$0	$0
TESSA CHURCHILL MD	SECRETARY	0.50	Officer Director	$0	$0	$0
LAURENCE ALBIGES MD PHD	DIRECTOR	0.50	Director	$0	$0	$0
MAHUL B AMIN MD	DIRECTOR	0.50	Director	$0	$0	$0
NOAH BUNTMAN	DIRECTOR	1.00	Director	$0	$0	$0
RONALD BUKOWSKI MD	DIRECTOR	0.50	Director	$0	$0	$0
CRAIG DEPRIESTER	DIRECTOR	0.50	Director	$0	$0	$0
DANIEL GEORGE MD	DIRECTOR	0.50	Director	$0	$0	$0
JAMIE GRAVES	DIRECTOR	0.50	Director	$0	$0	$0
DAVID PERRY ESQ	DIRECTOR	0.50	Director	$0	$0	$0
SHELLEY ROBSON	DIRECTOR	0.50	Director	$0	$0	$0
BRIAN SHUCH MD	DIRECTOR	0.50	Director	$0	$0	$0
LAURA WOOD RN	DIRECTOR	0.50	Director	$0	$0	$0
RUBEN YBARRA	DIRECTOR	0.50	Director	$0	$0	$0
GRETCHEN VAUGHAN	PRESIDENT & CEO	40.00	Officer	$339,752	$26,851	$366,603
KENDALL MONROE	CHIEF ADVANCEMENT OFFICER	40.00	Officer	$238,378	$28,538	$266,916
SALVATORE LA ROSA	CHIEF SCIENTIFIC OFFICER	40.00	Officer	$213,177	$17,180	$230,357
LARANDA BURKE	CHIEF FINANCIAL OFFICER	40.00	Officer	$197,400	$25,282	$222,682
MICHAEL NATHAN HAUBRICH	DIRECTOR OF FINANCE	0.50	Officer	$0	$0	$0
RADHA CHITALE	SR. DIRECTOR OF COMMUNICATIONS	40.00	Highest	$115,359	$16,343	$131,702
ANGELA WASHINGTON	DIRCTOR OF OPERATIONS	40.00	Highest	$114,633	$16,307	$130,940

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$4,942,029	$5,273,610	$26,510,439	$-331,581
2023	$2,379,639	$4,741,209	$23,797,390	$-2,361,570
2022	$6,390,706	$4,519,204	$23,316,300	$1,871,502
2021	$4,834,988	$4,449,597	$30,008,041	$385,391
2020	$1,596,880	$3,985,372	$26,386,607	$-2,388,492
2019	$3,618,834	$3,312,610	$28,703,578	$306,224
2018	$4,430,864	$1,659,702	$26,405,110	$2,771,162